Physician profile
Erin Healy
NPI 1508533688
$575.54
in general payments reported to CMS, 2019-2025
12 companies · $202 in 2025
The $202 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $166 · 2022: $49.61 · 2023: $77.62 · 2024: $80.51 · 2025: $202.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $360.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $360.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neurelis, INC. | $124.99 | 2021 | |
| Pfizer INC. | $93.59 | 2023-2025 | |
| Merck Sharp & Dohme LLC | $66.91 | 2021-2025 | Gardasil 9, Vaxneuvance, Vaqta |
| Sanofi Pasteur INC. | $56.68 | 2021-2023 | |
| Glaxosmithkline, LLC. | $49.44 | 2022-2024 | Bexsero |
| Dexcom, INC. | $39.63 | 2025 | Dexcom G6 Transmitter |
| Ani Pharmaceuticals, INC. | $31.92 | 2025 | Purified Cortrophin Gel |
| Gilead Sciences, INC. | $30.01 | 2024 | |
| Ultragenyx Pharmaceutical INC. | $23.40 | 2025 | Crysvita |
| Cumberland Pharmaceuticals, INC. | $21.02 | 2025 | Kristalose |
| Corium, LLC | $20.51 | 2022 | |
| Ars Pharmaceuticals Operations, INC. | $17.44 | 2025 | Neffy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erin Healy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.